AbbVie has completed the acquisition of Syndesi Therapeutics SA, which will help to expand AbbVie's neuroscience portfolio.
Originally, Belgian Syndesi was created in 2017 through a partnership between UCB Biopharma SRL and a syndicate of Belgian and international investors led by Novo Holdings to advance UCB’s SV2A modulator SDI-118. Syndesi's unique molecules act pre-synaptically to enhance synaptic efficiency by positively modulating the function of synaptic vesicle protein 2A (SV2A), which plays a central role in regulating neurotransmission.
SDI-118 is currently evaluated in Phase Ib studies as a imodulator of cognitive impairment and other symptoms associated with a range of neuropsychiatric and neurodegenerative disorders, such as Alzheimer's disease and major depressive disorder.
Under the terms of the agreement, AbbVie will pay Syndesi a $130m upfront and potential milestone payments of up to $870m.
Transine Therapeutics stressed it will use the proceeds to accelerate its preclinical pipeline of novel therapeutic RNAs (SINEUPs) capable of...
The financing was co-led by new investors Forbion and Sofinnova Partners. Existing investors, Novo Holdings, Morningside Ventures, Cowen Healthcare...
he EU Commission has launched its final consultation on the deregulation of new breeding techniques in agriculture. A study commissioned by the...
On Monday, CureVac filed a lawsuit in the German Regional Court in Düsseldorf against BioNTech SE and two of its subsidiaries, seeking compensation...
Roches new developed immunotherapy is based on a bispecific antibody, which targets B-lymphocyte antigen CD20 and the CD3-T-cell receptor at the...
Biosimilar natalizumab was developed by scientists at Polpharma Biologics (Poland) and the company retains responsibility for the manufacturing and...
With around EUR100m in previous financing rounds ImCheck’s financial position looks 'solidified' to take on the leadership in the gamma-delta T cell...
Break free from the long reaction times, high costs, and method complexity of manual proteomic sample preparation with the Thermo...
SIGN UP FOR OUR FREE NEWSLETTER